Focus: Paxman is a UK-based biotechnology company specializing in scalp cooling systems designed to prevent chemotherapy-induced hair loss and related conditions in cancer patients. The company operates as a focused medical device and therapeutic innovator with a narrow but clinically important product portfolio.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Paxman to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead product addressing chemotherapy-induced alopecia with multiple indications and Phase 2 development ongoing for metastatic breast cancer.
Help build intelligence for Paxman
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Paxman's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Expansion into peripheral neuropathy management represents pipeline diversification beyond scalp cooling into complementary oncology supportive care.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo